8:05am ET
Investing
5 S&P Winners, 5 Losers in Monday’s Premarket
Here's a look at how markets were shaping up for Monday's opening bell.
PFE Coverage Page 28
11:45am ET
Investing
Wednesday Afternoon Analyst Upgrades and Downgrades: Altria, BP, Peloton, Pfizer and More
Wednesday afternoon's top analyst upgrades and downgrades included Adobe, Altria, Amgen, Beyond Meat, BP, Murphy Oil, Northrop Grumman, Occidental Petroleum, Peloton Interactive, Pfizer, Salesforce.com and 3M.
9:03am ET
Investing
Tuesday’s Top Analyst Upgrades and Downgrades: Broadcom, Canadian Pacific, Coca-Cola, Eli Lilly, Marvell Technology, Pfizer, Regions Financial, Synchrony Financial, Tesla and More
Tuesday's top analyst upgrades and downgrades included Broadcom, Carrier Global, Canadian Pacific Railway, Coca-Cola, Eli Lilly, Marvell Technology, Pfizer, Regions Financial, Stryker, Synchrony Financial, Tesla and Zillow.
11:45am ET
Investing
Monday Afternoon’s Analyst Upgrades and Downgrades: Activision, Lucid, Nokia, Pfizer, SoFi and More
Monday afternoon's top analyst upgrades and downgrades included Activision Blizzard, Lucid, Nokia, Pfizer, SoFi Technologies, Sunrun and Welltower.
8:56am ET
Investing
Monday’s Top Analyst Upgrades and Downgrades: Apple, Coca-Cola, CommScope, Coupa Software, HubSpot, Merck, NetApp, Pfizer, Shopify and More
Monday’s top analyst upgrades and downgrades included Apple, Coca-Cola, CommScope, Coupa Software, GoPro, HubSpot, Merck, NetApp, Pfizer, Shopify, Spirit Airlines and Warner Music.
11:50am ET
Investing
Thursday Afternoon’s Analyst Upgrades and Downgrades: AbbVie, Occidental Petroleum, Pfizer, Yum! Brands and More
Thursday afternoon's top analyst upgrades and downgrades included AbbVie, Allstate, Amgen, Occidental Petroleum, Pfizer, SunPower, Twilio and Yum! Brands.
10:32am ET
Investing
5 ‘Strong Buy’ Blue Chip Stocks With Dividend Hikes Expected This Week
Broadcom, Pfizer and these other top companies are expected to lift the dividends they pay to shareholders, and their stocks are rated Buy across Wall Street, making them excellent total return candidates.
7:23am ET
Investing
5 Dividend Stocks Could Be Big Winners After the New COVID-19 Variant Shock
These five stay-at-home and pharmaceutical stocks perhaps make sense now, on concerns over the Omicron variant of COVID-19. They are Buy rated and pay solid dividends, and they may be solid ideas…
8:53am ET
Investing
Friday’s Top Analyst Upgrades and Downgrades: FedEx, Fiserv, Gilead Sciences, Nvidia, Pfizer, Target, TJX, Victoria’s Secret and More
Friday's top analyst upgrades and downgrades included Arista Networks, DataDog, FedEx, Fiserv, Gilead Sciences, Global Payments, Nvidia, Oatly, Pfizer, Target, TJX Companies and Victoria’s Secret.
7:50am ET
Investing
Cathie Wood’s ARK Invest Sells Over 400,000 More Shares of Pfizer
One of Cathie Wood's ARK Invest exchange-traded funds sold over 400,000 shares of Pfizer on November 11.
7:35am ET
Investing
Cathie Wood’s ARK Invest Sells Over 140,000 More Shares of Pfizer
One of Cathie Wood's ARK Invest exchange-traded funds sold over 140,000 shares of Pfizer on November 10.
7:45am ET
Investing
Cathie Wood’s ARK Invest Sells Over 230,000 Shares of Pfizer
One of Cathie Wood's ARK Invest exchange-traded funds sold over 230,000 shares of Pfizer on November 9.
12:21pm ET
Investing
Earnings Previews: BP, Pfizer, Under Armour
An oil and gas supermajor looking to transform its business, a Dow component and a struggling athletic gear company are reporting earnings before markets open Tuesday.
7:15am ET
Investing
Cathie Wood’s ARK Invest Buys Over 180,000 Shares of Pfizer
One of Cathie Wood's ARK Invest exchange-traded funds bought over 180,000 shares of Pfizer on September 7.
7:05am ET
Investing
Cathie Wood’s ARK Invest Buys Over 380,000 Shares of Pfizer
One of Cathie Wood's ARK Invest exchange-traded funds bought over 380,000 shares of Pfizer on September 1.